SAveRUNNER is a recently developed network-based tool to efficiently identify novel
medical indications for currently approved drugs (known as drug repurposing strategy). Up …

Drug repurposing is a cost-effective method of discovering new treatments for diseases than
traditional drug development methods. It involves virtual screening of chemical candidates …

Personalized medicine aims to tailor the health care to each person's unique signature
leading to better distinguish an individual patient from the others with similar clinical …

Cardiovascular disease is the second leading cause of death in cancer survivors. As a
result, the cardio-oncology field was established to explore the connection between cancer …

Seit einigen Jahrzehnten werden bei der Entwicklung und Repositionierung von
Arzneimitteln rechenintensive computergestützte Methoden eingesetzt, insbesondere da …

The COVID-19 coronavirus has wreaked havoc on the world and medical community.
Treating individuals during a worldwide pandemic is nothing short of heroic. With limited …

Background: Multiple myeloma (MM) remains a lethal blood malignancy, so new drugs are
necessary in order to treat this cancer more effectively. Different types of in silico analyses …

Abstract Development of new drugs has the limitations of high cost, high time requirement
and low success rate. If an existing drug can be used to treat a drug-seeking disease, we …

Traditional drug development is a resource-intensive and time-consuming process with a
high rate of failure. To expedite this process, researchers have turned to computational …